CV CapsoVision, Inc.
$7.06▲ +4.59%
Healthcare
Other
After hours
$7.05▼ -0.08%
Oct 28, 4:46 PM ET
Volume 177.5K
Avg Volume (10D) 136.9K
Key Metrics & Fundamentals
Market Cap
$375.67M
P/E Ratio
–
Div Yield
0.00%
52W Range
4.50 - 15.37
% vs 50 MA
10.50%
% vs 200 MA
11.33%
RSI-14
60.6
MACD Histogram
+0.0300
Beta (1Y vs SPY)
0.71
Free Cash Flow
-$8.40M
Gross Rev
$3.64M
Gross Profit
$1.87M
EBITDA
-$7.42M
COGS
$1.77M
Operating Exp
$9.45M
Operating Income
-$7.58M
EBIT
-$7.58M
Pretax Income
-$7.48M
Net Income
-$7.48M
EPS (Diluted)
-0.15
Price & Volume History
Loading chart…
Recent News

CapsoVision Maps AI Capsule Push Into Colon, Pancreatic Cancer Screening
MarketBeat · Oct 24, 2026 4:02 AM ET

CapsoVision to Present at the 20th Annual LD Micro Main Event
GlobeNewswire · Oct 13, 2026 4:05 PM ET

CapsoVision Announces FDA Clearance of AI Highlights for CapsoCam Plus®
GlobeNewswire · Sep 28, 2026 9:00 AM ET
CapsoVision Insider Bought Shares Worth $9,999,999, According to a Recent SEC Filing
MT Newswires · Sep 24, 2026 4:24 AM ET
CapsoVision Insider Bought Shares Worth $4,999,996, According to a Recent SEC Filing
MT Newswires · Sep 21, 2026 4:00 AM ET

CapsoVision to Participate in Upcoming Investor Conferences
GlobeNewswire · Sep 3, 2026 4:05 PM ET
Outlook Therapeutics Appoints Kevin Lundquist as CFO
MT Newswires · Aug 27, 2026 4:39 PM ET
CapsoVision Inc (CV) (Q2 2026) Earnings Call Highlights: AI Launch Drives Growth Amid Pricing ...
GuruFocus.com · Aug 14, 2026 1:01 AM ET

CapsoVision Q2 Earnings Call Highlights
MarketBeat · Aug 13, 2026 7:04 PM ET
CapsoVision Files Mixed Shelf for Up to $250 Million in Securities
MT Newswires · Aug 13, 2026 5:18 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See CV's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.